팜유 제조 공정 부산물을 이용한 농후사료 및 이의 제조방법
    52.
    发明公开
    팜유 제조 공정 부산물을 이용한 농후사료 및 이의 제조방법 有权
    使用棕榈油生产的浓缩饲料及其制备方法

    公开(公告)号:KR1020140060124A

    公开(公告)日:2014-05-19

    申请号:KR1020120126826

    申请日:2012-11-09

    CPC classification number: Y02P60/877 A23K10/37 A23K40/20

    Abstract: The present invention uses pulp generated as by-products in a palm oil production process or hydrolysate thereof, or additionally mixes a supplementary material to convert to concentrate feed, which rates of carbohydrate, protein and fat are well adjusted. Therefore, high value can be added to the by-products continuously produced in the palm oil production process, and waste can be significantly reduced.

    Abstract translation: 本发明使用在棕榈油生产方法或其水解产物中作为副产物产生的纸浆,或者另外混合补充材料以转化成浓缩饲料,其中碳水化合物,蛋白质和脂肪的速率被很好地调节。 因此,可以在棕榈油生产过程中连续生产的副产物中增加高价值,并且可以显着降低废物。

    작약 종자 추출물, 이의 분획물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 퇴행성 뇌질환 예방 또는 치료용 약학적 조성물
    54.
    发明公开
    작약 종자 추출물, 이의 분획물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 퇴행성 뇌질환 예방 또는 치료용 약학적 조성물 有权
    包含提取物的活性成分的药物组合物,其分离物或其分离的化合物作为活性成分

    公开(公告)号:KR1020120016861A

    公开(公告)日:2012-02-27

    申请号:KR1020100079356

    申请日:2010-08-17

    Abstract: PURPOSE: A pharmaceutical composition containing Paeonia lactiflora seed extract, fraction thereof, or compound isolated from the same is provided to suppress BACE-1 activity and to treat and prevent neurodegenerative diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating neurodegenerative diseases contains Paeonia lactiflora seed extract as an active ingredient. The neurodegenerative diseases include Alzheimer's dieses, Parkinsons's disease, progressive supranuclear palsy. The extract is prepared using water, alcohol of C1-C4, or mixture solvent thereof. The pharmaceutical composition contains Paeonia lactiflora seed fraction as an active ingredient. The pharmaceutical composition also contains compounds as an active ingredient. The method for preparing the compounds comprises: a step of adding water, C1-C3 alcohol, or mixture thereof to the Paeonia lactiflora seeds to prepare Paeonia lactiflora seed extract; a step of fractioning the extract with water, dichloromethane, and ethyl acetate to prepare a fraction; a step of performing silicagel column chromatography of the fraction.

    Abstract translation: 目的:提供含有芍药提取物,其部分或从其分离的化合物的药物组合物以抑制BACE-1活性并治疗和预防神经变性疾病。 构成:用于预防或治疗神经变性疾病的药物组合物含有芍药种子提取物作为活性成分。 神经变性疾病包括阿尔茨海默氏病,帕金森氏病,进行性核上性麻痹。 萃取液用水,C1-C4的醇或其混合溶剂制备。 该药物组合物含有作为活性成分的芍药芍药种子。 药物组合物还含有作为活性成分的化合物。 制备化合物的方法包括:将水,C1-C3醇或其混合物加入到芍药种子中以制备芍药提取物的步骤; 用水,二氯甲烷和乙酸乙酯分级提取物以制备级分的步骤; 进行该级分的硅胶柱色谱的步骤。

    포도나무 수피로부터 분리된 BACE-1 저해 효과를 갖는활성물질을 포함하는 퇴행성 뇌질환의 예방 또는 치료용조성물
    56.
    发明公开
    포도나무 수피로부터 분리된 BACE-1 저해 효과를 갖는활성물질을 포함하는 퇴행성 뇌질환의 예방 또는 치료용조성물 有权
    用于预防或治疗包含活性成分的神经病变组合物,其从VITIS VINIFERA的标准分离,其对BACE-1具有抑制作用

    公开(公告)号:KR1020080025655A

    公开(公告)日:2008-03-21

    申请号:KR1020070095884

    申请日:2007-09-20

    Abstract: A composition comprising an extract of stembark of Vitis vinifera is provided to inhibit BACE-1(beta-site APP-cleaving enzyme 1) mediating formation of beta-amyloid, known to be a causing material of various dementia such as Alzheimer's disease, thereby being usefully used for preventing and treating neurodegenerative diseases such as senile dementia. A pharmaceutical composition for preventing or treating neurodegenerative diseases comprises a compound selected from the group consisting of vitisin A, epsilon-viniferin, ampelopsin A and a mixture thereof as an effective ingredient, wherein the compound is obtained by extracting stembark of Vitis vinifera with an organic solvent selected from the group consisting of C1-4 alcohol and an aqueous solution thereof, dichloromethane, ethyl acetate and a mixture thereof.

    Abstract translation: 提供了包含葡萄树葡萄树的提取物的组合物以抑制介导β-淀粉样蛋白形成的BACE-1(β-位点APP切割酶1),已知其是引起各种痴呆的物质,例如阿尔茨海默病,因此是 有用地用于预防和治疗老年性痴呆等神经变性疾病。 用于预防或治疗神经退行性疾病的药物组合物包括选自维生素A,ε-荧光素,安非他酮A及其混合物作为有效成分的化合物,其中所述化合物通过用有机物提取葡萄葡萄树 溶剂,其选自C1-4醇及其水溶液,二氯甲烷,乙酸乙酯及其混合物。

    제초성 퀴놀리닐옥사디아졸 유도체
    58.
    发明授权
    제초성 퀴놀리닐옥사디아졸 유도체 失效
    含有喹啉衍生物的喹喔啉衍生物

    公开(公告)号:KR1019970011302B1

    公开(公告)日:1997-07-09

    申请号:KR1019930015668

    申请日:1993-08-13

    Abstract: Quinolinyl oxadiazole derivatives having strong herbicidal activities and excellent selectivity, especially on rice and barnyard grass, is disclosed in the present invention. Hydroxylamine chlorinate and nitrile compound are reacted in mixture solvent of water and alcohols in the presence of base to yield amidoxime. Thereafter, in the presence of base, said amidoxide is reacted with carboxylic acid chloride produced by the reaction of 3,7-dichloro-8-quinoline carboxylate and thionyl chloride to yield compound of general formula(I). In general formula(I), A and B represent hydrogen atom, sodium carbonate, etc., R represents low molecular weight alkyl, cyclo alkyl, etc.

    Abstract translation: 在本发明中公开了具有强除草活性和优异选择性的喹啉基恶二唑衍生物,特别是在水稻和稗草上。 羟基胺氯化物和腈化合物在水和醇的混合溶剂中在碱的存在下反应,得到偕胺肟。 此后,在碱的存在下,所述酰胺氧化物与通过3,7-二氯-8-喹啉羧酸盐和亚硫酰氯反应生成的羧酸氯化物反应,得到通式(I)的化合物。 在通式(I)中,A和B表示氢原子,碳酸钠等,R表示低分子量烷基,环烷基等。

    신규 피라졸로[3,4-d]피리미딘 유도체, 그 제조방법 및 그로서 된 제초제
    60.
    发明授权
    신규 피라졸로[3,4-d]피리미딘 유도체, 그 제조방법 및 그로서 된 제초제 失效
    新型吡咯(3,4-D)吡嗪衍生物及其制备方法及其组合物

    公开(公告)号:KR1019950010076B1

    公开(公告)日:1995-09-06

    申请号:KR1019920011757

    申请日:1992-07-02

    Abstract: The 5-substd phenyl-pyrazolo[3,4-d pyrimidine and 5-substd. phenyl-4-oxo-pyrazolo [3,4-d pyrimidine derivative of formula(I) is prepared. In (I), R1 is C1-4 alkyl or haloalkyl; R2 is H or C1-4 alkyl; R3 is H, C1-6 alkyl, haloalkyl, alkenyl or acyl, R4 and R5 are each halogen; A is H, alkyl, alkoxy, nitro, amino, alkyl amine, dialkyl amine or CO2R; R is H, C1-6 alkyl, substd. alkyl, haloalkyl or alkenyl [A = carboxylic acid or its ester . The cpd. (I) has a good selective herbicidal characteristic against esp. cotton plants.

    Abstract translation: 5-取代苯基 - 吡唑并[3,4-d嘧啶和5-取代基。 制备式(I)的苯基-4-氧代 - 吡唑并[3,4-d嘧啶衍生物。 在(I)中,R 1为C 1-4烷基或卤代烷基; R2是H或C1-4烷基; R3是H,C1-6烷基,卤代烷基,烯基或酰基,R4和R5分别是卤素; A是H,烷基,烷氧基,硝基,氨基,烷基胺,二烷基胺或CO 2 R; R是H,C 1-6烷基,被取代。 烷基,卤代烷基或烯基[A =羧酸或其酯。 cpd。 (I)具有良好的选择性除草特性。 棉花植物。

Patent Agency Ranking